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Abstract
Objective: The purpose of this study was to determine the effect of various chitosan concentration on the 
psychochemical characteristic, the solubility, and dissolution of andrographolide-chitosan solid dispersion system. 
Materials and Methods: Andrographolide-chitosan solid dispersion system was prepared by solvent wetting-
spray drying method in various drug to polymer ratio of 1:1, 1:2, 1:3, 1:4, and 1:5. The results were evaluated 
for morphology, physical state, drug content, solubility, and dissolution rate. Results and Discussion: The 
andrographolide-chitosan solid dispersion system particles showed spherical shapes analyzed by scanning electron 
microscopy. Infrared spectra of solid dispersion systems showed a similar absorption pattern as the drug compound. 
Differential thermal analysis and X-ray diffraction analysis showed a reduction in melting point and crystal 
intensity. The study revealed a 1.75 times increase in andrographolide-chitosan solid dispersion system solubility 
and 3.1 times for dissolution rate compared to andrographolide compound, respectively. Conclusion: An increase 
in chitosan amount in andrographolide-chitosan solid dispersion system resulted in decreasing crystallinity and a 
melting point of andrographolide, which had a positive effect on increasing solubility and dissolution rate.
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INTRODUCTION
Andrographolide possesses several important biological activities, including hepatoprotective, immune 
system enhancer, anti-inflammatory, 
antioxidant, antidiarrheal, and antimalarial 
agent. Low andrographolide solubility (3.29± 
0.79 µg/mL) in water and very lipophile 
character (log P = 2.632 ± 0.135) result in 
a very low bioavailability (2.67%).[1-3] One 
method that can be used to improve solubility 
is the preparation of nanoparticles, whereas the 
reduction of particle size can elevate surface 
area and increase solubility. However, the lack 
of this system is at very small sizes can cause 
agglomeration and aggregation, to prevent this 
problem a solid dispersion system is chosen. [4] 
Solid dispersion is the distribution of one or 
more active ingredients in the carrier in the form 
of an inert matrix prepared by a melting method, 
solvent wetting method, or combination.[5,6] 
Solid dispersion systems have advantages 
such as particle size reduction, improving the 
wetting process, physical change, and molecular dispersed 
that change the solubility of the drug in water and easily 
applied and produced in comparison to prodrug.[6,7] The 
use of polymers as carriers of solid dispersion systems can 
reduce the crystallinity of the drug ingredients become 
more amorphous. The amorphous formation can reduce the 
melting point of medicinal ingredients, so the energy needed 
to dissolve the drug ingredients becomes lower than the 
crystal shape that has a regular lattice.[8]
Chitosan is a natural polymer derived from chitin derivatives 
which have N-deacetylation. This polymer is widely used 
due to its biocompatible, biodegradable, and non-toxic 
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effect.[9] Chitosan is hydrophilic because it has an amine 
group that is easily protonated.[10] The formation of a solid 
dispersion system from chitosan polymer extend the surface 
area, inhibit recrystallization, wetting effect, solubilization, 
and dissolution rate so that the drug bioavailability was 
increased.[7,11]
Solid dispersion system was prepared by the spray drying 
method, which the drug and polymers dissolved in each 
solvent and dried by spray drying. This process was able 
to reduce high humidity and prevents chemical damage to 
the drug.[7,8] The aim of this study is to determine the effect 
of increasing chitosan amount on physical characteristics, 
solubility, and dissolution of andrographolide-chitosan solid 
dispersion system prepared by the spray-drying method. The 
evaluation includes morphology, X-ray diffraction (XRD), 
melting point, solubility test, and dissolution rate were 
conducted.
MATERIALS AND METHODS
Andrographolide (RD Health Ingredients Co., Ltd.); Chitosan 
(87.5% degree of deacetylation, viscosity 1% 18.16  mPa.s, 
China Eastar Group Co., Ltd.); methanol pro analysis, NaOH, 
KH2PO4, and aquadest were used.
Preparation of andrographolide‑chitosan solid 
dispersion system
Andrographolide-chitosan solid dispersion system was 
formed by the solvent wetting method and spray dried. The 
solid dispersion were prepared with andrographolide-chitosan 
ratio of 1:1, 1:2, 1:3, 1:4 and 1:5. Chitosan was dissolved in 
50 mL of 0.3% acetic acid solution. Andrographolide was 
dissolved in 10 mL of methanol. The solution of chitosan was 
added into andrographolide solution and stirred at a speed 
of 500 rpm for 1 h then spray dried. The process parameters 
were as followed: nozzle diameter 1.0 mm, inlet temperature 
100°C, flow rate 3 mL/min, and 2 bar pressure.
Morphology evaluation
The shape and surface morphology of the particles was 
observed using scanning electron microscopy. Particles 
were embedded in a holder made of aluminum and coated 
with gold-palladium before analysis. Pictures were taken at 
various magnifications at 20.00 kV.
Fourier transform‑infrared (FT‑IR) analysis
Particles were made as a pellet by mixing with KBr powder 
then pressed with a hydraulic pump to form a transparent 
pellet. Sample observation was conducted at wavelength 
4000–450 cm−1 (Jasco FT-IR 5300, Easton MD, USA).
Differential thermal analysis (DTA)
Thermal analysis of the sample was conducted with DTA 
(DTA FP-65 P-900 Thermal, Mettler Toledo, USA). About 
5 mg of particles were placed in a crucible pan, sealed and 
observed for its thermogram. The thermogram was recorded 
at temperature 5–250°C with a heating rate 10°C/min.
XRD analysis
XRD analysis was conducted by Philips X’Pert X-ray 
diffractometer to evaluate sample’s crystallinity. The light 
source employed was Kα Cu Ni. The voltage and the current 
were set at 40 kV and 40 mA. Samples were analyzed at 
2Ø and angle between 5 and 40°. The diffractogram of the 
andrographolide-carboxymethyl chitosan particles was 
compared with diffractogram of andrographolide substance.
Drug content
The andrographolide content in solid dispersion system 
was determined by ultraviolet (UV)-Visible double-beam 
spectrophotometer (Hitachi UH5300, Japan) at a wavelength 
of 225 nm. An amount of 10.0 mg of sample was carefully 
weighed and dissolved in 5 ml of methanol, filtered with a 
0.45 μm filter membrane and then analyzed at wavelength 
225 nm. The analysis was replicated three times.
The drug content was calculated using the equations below:
drug amount
% Drug content  1 00%
 particle weight 
= ×
Solubility test
Solubility test was carried out in 15 ml phosphate buffer, 
pH 7.0 ± 0.05. The sample put into a shaker water bath with 
120 rpm speed, at a temperature of 37.0 ± 0.5°C. Samples were 
taken 1 mL and filtered with 0.45 µm Millipore filter paper. 
The absorbance was observed using UV-Visible double-beam 
spectrophotometer (Hitachi UH5300, Japan) with a wavelength 
of 225 nm. Solubility test was replicated 3 times.
Dissolution test
The dissolution test was carried out in 50 ml of phosphate buffer 
pH 7.0 ± 0,05 at 37.0 ± 0.5°C, and 120 rpm at water bath shaker. 
The andrographolide-chitosan, solid dispersion system, was 
weighed equivalent to 5.0 mg andrographolide and put into the 
media. 2.0 ml sample was taken intervals of 5, 15, 30, 60, 120, 
180, 240, and 300 minutes. After sampling, 2.0 ml media were 
added. Samples were analyzed by UV-Visible double-beam 
spectrophotometer (Hitachi UH5300, Japan) at a wavelength 
of 225 nm. The amount of andrographolide dissolved from 
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the andrographolide substance and solid dispersion system of 
andrographolide-chitosan were calculated. The dissolution test 
was carried out 3 times of replication.
RESULTS AND DISCUSSION
Morphology evaluation
The results of the morphological evaluation of 
andrographolide-chitosan solid dispersion system with the 
ratio of 1:1, 1:2, 1:3, 1:4, and 1:5 can be seen in Figure 1. It 
was concluded that the higher the ratio of chitosan used in 
the formula, the more spherical shapes were formed and less 
andrographolide crystals were found.
FT‑IR analysis
IR spectrum of andrographolide, chitosan, and 
andrographolide-chitosan solid dispersion system was 
presented in Figure 2. The spectrum of chitosan (b) showed 
a broadband at 3353–3284 cm−1 attributed to O-H and 
N-H stretching vibrations of the functional group engaged 
in intramolecular hydrogen bonding between chitosan 
molecules.[12] There was a sharp peak found at wave numbers 
1727.3 cm−1 which is the specific C=O spectrum from 
andrographolide (a), and also at 1725, 1680 cm−1; 1640, 
1480 cm−1; 1220, 1240 cm−1; and 980, 1040, 1090 cm−1, 
may be due to the presence of C=O, C=C, C-O-C of lactone 
ring, and O-H group of alcohol, respectively, which also 
present in the molecular structure of andrographolide. [13,14] 
An absorption of amide and amine groups was occurred in 
solid dispersion system (C to G spectra). The widening and 
shifting of the peak indicate that the intermolecular hydrogen 
bonds were formed between andrographolide and chitosan.[15]
Thermal analysis using DTA
The results of the thermal analysis in Figure 3 showed the 
high and sharp melting peak of andrographolide occurred 
at 231.6°C. Andrographolide has an endothermic peak at 
230°C.[16] In the DTA thermogram of chitosan, there was a 
widened endothermic peak at 175°C. Endothermic peak 
Figure 2: Infrared spectrum of (a) andrographolide, 
(b) chitosan, and andrographolide-chitosan solid dispersion 
system with various drug-polymer ratio: (c) 1:1, (d)1:2, (e),1:3 
(f) 1:4, and (g) 1:5
Figure 3: The differential thermal analaysis thermogram 
of (a) andrographolide, (b) chitosan, and andrographolide-
chitosan solid dispersion system with various drug-polymer 
ratio: (c) 1:1, (d) 1:2, (e) 1:3, (f) 1:4, and (g) 1:5
Figure 4: X-ray diffractograms of (a) andrographolide, 
(b) chitosan, and andrographolide-chitosan solid dispersion 
system with various drug-polymer ratio: (c) 1:1, (d) 1:2, (e) 1:3 
(f) 1:4, and (g) 1:5
Figure 1: Scanning electron microscopy micrograph of 
andrographolide-chitosan solid dispersion system with 
various drug-polymer ratio (a) 1:1, (b) 1:2, (c) 1:3, (d) 1:4, and 
(e) 1:5 with ×20000 magnification
a
d
b c
e
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shifting was found in thermogram C to G, with lower melting 
point shown at 214.9°C and 227.4°C, 179.5°C and 218.8°C, 
184.0°C, 166.4°C, and 155.1°C in andrographolide-chitosan 
solid dispersion system 1:1, 1:2, 1:3, 1:4, and 1:5, respectively. 
These result demonstrated the changes of crystalline form of 
andrographolide to amorphous form.
XRD analysis
Figure 4 showed the andrographolide diffractogram which 
has high intensity at 2θ = Ø 9.83°, 14.81°, 15.69°, and 15.85°. 
Andrographolide has a specific peak at 2θ = 12.2; 13.3; 15.4; 
nd 25.9°.[16] Chitosan diffraction was plateau-shaped with no 
apparent diffraction peaks; this indicated an arrangement of 
molecules that tend to be amorphous. In the solid dispersion 
system, there was a decrease in diffraction intensity which 
showed the reduction in particle size and change in the 
physical state of the crystal to an amorphous state.[15,17]
Drug content
Drug content evaluation was carried out with 
spectrophotometry UV-Visible method. Determination of the 
content was carried out on an andrographolide-chitosan solid 
dispersion system 1:3 (F3), 1:4 (F4), and 1:5 (F5) because 
it only showed a single endothermic peak, low XRD, and 
spherical photomicrographs. The result of andrographolide 
content from the andrographolide-chitosan solid dispersion 
system for F3, F4, and F5 was 31.19 ± 0.19%, 26.02 ± 1.05%, 
and 28.47 ± 0.36%, respectively.
Solubility test
The results of the solubility test in Table 1 showed that the 
solubility of F3 formula increased by 1.32 times, where F4 and 
F5 formula multiplied by 1.75 times than the andrographolide 
substances. The increase in andrographolide solubility was 
caused by the dispersion of andrographolide between chitosan 
matrixes so that it showed amorphization, increasing surface 
area, and andrographolide wetting ability.[18]
Dissolution test
The dissolution test was carried out on a phosphate buffer 
pH 7.0 ± 0.05. Figure 5 showed that the andrographolide 
dissolved from the solid dispersion increased compared to 
andrographolide substances.
The andrographolide dissolution rate was 3.79 ± 
0.64% mg/min−1, whereas the F3 solid dispersion system 
was 10.02 ± 0.60 mg/min−1, F4 10.17 ± 0.48 mg/min−1, and 
F5 increased up to 12.08 ± 0.74 mg/min−1. Statistical analysis 
indicated that the release rate of andrographolide and solid 
dispersion systems in all formula was significantly different, 
whereas the solid dispersion systems of F3 and F4 were 
significantly different with F5 [Table 2].
These results indicated that the formation of a solid 
dispersion system improved the dissolution rate of 
andrographolide because an increase in surface area 
which raises the dissolution rates, inhibit recrystallization, 
wetting, and solubilization effects.[18] In accordance with 
DTA thermogram and XRD diffractogram in Figure 3 and 
4, the solid dispersion system showed a transformation 
of crystallinity to an amorphous state. The amorphous 
formation was able to reduce the melting point of the drug, 
so lessen energy was needed to dissolve than the crystal 
shape which has a regular lattice.[8]
CONCLUSION
The formation of solid andrographolide-chitosan dispersion 
system affected drug characteristics, such as decreasing of 
drug crystallinity and lower melting point, caused a good 
impact to andrographolide solubility and dissolution rate. 
The solubility and dissolution rate of andrographolide 
was enhanced up to 1.75 times and 3.1 times compared to 
andrographolide substances, respectively.
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